In conclusion, evidence is accumulating that low SHBG levels are an indicator of IR, and SHBG may be an easy-to-measure and clinically useful biomarker for the early identification of children who are destined to develop obesity-related chronic diseases. This evidence concerns the gene SHBG and obesity due to melanocortin 4 receptor deficiency.